Literature DB >> 22960360

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.

Chunhui Jin1, Weidong Li, Jianmin Yuan, Wenwei Xu, Zaohuo Cheng.   

Abstract

It is well known that genetic variants play a critical role in the pathogenesis of Alzheimer's disease (AD). In 2009, a genome-wide association study (GWAS) demonstrated that a single nucleotide polymorphism (SNP), rs6656401, in complement receptor 1 (CR1) is significantly associated with late-onset Alzheimer's disease (LOAD) in Caucasian population. Subsequently, other researchers have attempted to validate this finding in Chinese Han populations. However, these findings in Chinese Han populations have produced both negative and positive results. To derive a more precise estimation for the relationship, we performed the present meta-analysis by analyzing three published association studies involving CR1 SNP rs6656401 through the use of the RevMan (v.5.1) program. Pooled odds ratios (ORs) were calculated for allele contrasts (A vs. G) and a dominant model [(AA+AG) vs. GG] in three studies that included 1019 cases and 1080 controls, respectively. The statistical results showed a significant difference between patients and controls for the A allele of CR1 SNP rs6656401 (P=0.005). In addition, carriers of the A allele (AA+AG) of rs6656401 had a 1.69-fold increased risk for LOAD compared with non-carriers (GG) (P=0.01). In conclusion, despite there are some limitations, this meta-analysis indicates that the A allele of the CR1 SNP rs6656401 is significantly associated with LOAD susceptibility in Chinese Han populations.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960360     DOI: 10.1016/j.neulet.2012.08.032

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.

Authors:  Jenny U Johansson; William D Brubaker; Harold Javitz; Andrew W Bergen; Denise Nishita; Abhishek Trigunaite; Andrés Crane; Justine Ceballos; Diego Mastroeni; Andrea J Tenner; Marwan Sabbagh; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2018-05-21       Impact factor: 21.566

2.  Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.

Authors:  William D Brubaker; Andrés Crane; Jenny U Johansson; Kevin Yen; Kristina Garfinkel; Diego Mastroeni; Priya Asok; Bonnie Bradt; Marwan Sabbagh; Tanya L Wallace; Courtney Glavis-Bloom; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-05-02       Impact factor: 21.566

Review 3.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

4.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.

Authors:  Andrés Crane; William D Brubaker; Jenny U Johansson; Abhishek Trigunaite; Justine Ceballos; Bonnie Bradt; Courtney Glavis-Bloom; Tanya L Wallace; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-07-26       Impact factor: 21.566

Review 5.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

6.  An Updated Analysis with 85,939 Samples Confirms the Association Between CR1 rs6656401 Polymorphism and Alzheimer's Disease.

Authors:  Ning Shen; Bin Chen; Yongshuai Jiang; Rennan Feng; Mingzhi Liao; Liangcai Zhang; Fujun Li; Guoda Ma; Zugen Chen; Bin Zhao; Keshen Li; Guiyou Liu
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

7.  CLU rs2279590 polymorphism contributes to Alzheimer's disease susceptibility in Caucasian and Asian populations.

Authors:  Shuyan Zhang; Donghui Zhang; Yongshuai Jiang; Lina Wu; Hong Shang; Jiafeng Liu; Rennan Feng; Mingzhi Liao; Liangcai Zhang; Yong Liu; Guiyou Liu; Keshen Li
Journal:  J Neural Transm (Vienna)       Date:  2014-06-20       Impact factor: 3.575

Review 8.  Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.

Authors:  Florence F Roussotte; Madelaine Daianu; Neda Jahanshad; Cassandra D Leonardo; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

Review 9.  Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer's disease susceptibility.

Authors:  Guiyou Liu; Fujun Li; Shuyan Zhang; Yongshuai Jiang; Guoda Ma; Hong Shang; Jiafeng Liu; Rennan Feng; Liangcai Zhang; Mingzhi Liao; Bin Zhao; Keshen Li
Journal:  Mol Neurobiol       Date:  2014-03-19       Impact factor: 5.590

10.  APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease.

Authors:  Qin Zhou; Dantao Peng; Xinrui Yuan; Zeping Lv; Shenghang Pang; Wenyu Jiang; Chuyu Yang; Xiaohong Shi; Guofang Pang; Yige Yang; Haiqun Xie; Wandong Zhang; Caiyou Hu; Ze Yang
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.